In this episode of The Biotech Startups Podcast, host Jon Chee continues his conversation with Stephanie Sirota, Partner and Head of Strategic Partnerships at RTW Investments, as she traces RTW’s evolution from a lean public-equity fund into a major life sciences platform spanning crossover investing, company creation, and global commercialization. Stephanie explains how RTW built the modern crossover ecosystem, why they chose to found Rocket Pharma instead of a fleet of gene therapy startups, and how a disciplined, science-first research process underpins the firm’s long-term, concentrated investing strategy and deep alignment with LPs and portfolio founders.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Excedr. Innehållet i podden är skapat av Excedr och inte av, eller tillsammans med, Poddtoppen.